Moreover, in an in vitro model of mouse cutaneous melanoma, pharmacological inhibition of EZH2 significantly reduced melanoma progression and decreased invasiveness, thereby leading to increased survival [35]. Here, EZH2 is linked to cutaneous melanoma.